0001209191-23-023829.txt : 20230407 0001209191-23-023829.hdr.sgml : 20230407 20230407171228 ACCESSION NUMBER: 0001209191-23-023829 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230407 DATE AS OF CHANGE: 20230407 EFFECTIVENESS DATE: 20230407 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALIMERA SCIENCES INC CENTRAL INDEX KEY: 0001267602 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200028718 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-478298 FILM NUMBER: 23809222 BUSINESS ADDRESS: STREET 1: 6310 TOWN SQUARE STREET 2: SUITE 400 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-990-5740 MAIL ADDRESS: STREET 1: 6310 TOWN SQUARE STREET 2: SUITE 400 CITY: ALPHARETTA STATE: GA ZIP: 30005 D 1 primary_doc.xml X0708 D LIVE 0001267602 ALIMERA SCIENCES INC 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 (678) 990-5740 DELAWARE None None Corporation true Richard S. Eiswirth, Jr. 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Executive Officer Director Philip Ashman 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Executive Officer David Holland 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Executive Officer Russell Skibsted 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Executive Officer Garheng Kong 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Director James R. Largent 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Director Daniel Myers 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Director Erin Parsons 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Director Peter J. Pizzo III 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Director Roger Sawheny 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Director John Snisarenko 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Director Pharmaceuticals $25,000,001 - $100,000,000 06b false 2023-03-24 false true true true false 0 27000000 12000000 15000000 Total Offering Amount consists of two tranches. Tranche one represented $12,000,000 of securities and tranche two represents an additional $15,000,000 of securities that may be sold on agreement between the Issuer and a majority of tranche one investors. false 4 0 0 0 false ALIMERA SCIENCES INC /s/ Richard S. Eiswirth, Jr. Richard S. Eiswirth, Jr. Chief Executive Officer 2023-04-07